Wen Sun1, Ji-Ping Liao2, Kun-Yao Yu1, Jian-Xing Qiu3, Chen-Li Que1, Guang-Fa Wang1, Jing Ma1. 1. Department of Pulmonary and Critical Care Medicine, Peking University First Hospital, Beijing, 100034, China. 2. Department of Pulmonary and Critical Care Medicine, Peking University First Hospital, Beijing, 100034, China. jipingliao@hotmail.com. 3. Department of Radiology, Peking University First Hospital, Beijing, 100034, China.
Abstract
BACKGROUND: With pandemic of coronavirus disease 2019 (COVID-19), human coronaviruses (HCoVs) have recently attached worldwide attention as essential pathogens in respiratory infection. HCoV-229E has been described as a rare cause of lower respiratory infection in immunocompetent adults. CASE PRESENTATION: We reported a 72-year-old man infected by HCoV-229E with rapid progression to acute respiratory distress syndrome, in conjunction with new onset atrial fibrillation, intensive care unit acquired weakness, and recurrent hospital acquired pneumonia. Clinical and radiological data were continuously collected. The absolute number of peripheral T cells and the level of complement components diminished initially and recovered after 2 months. The patient was successfully treated under intensive support care and discharged from the hospital after 3 months and followed. CONCLUSION: HCoV-229E might an essential causative agent of pulmonary inflammation and extensive lung damage. Supportive treatment was essential to HCoVs infection on account of a long duration of immunological recovery in critical HCoV-229E infection.
BACKGROUND: With pandemic of coronavirus disease 2019 (COVID-19), humancoronaviruses (HCoVs) have recently attached worldwide attention as essential pathogens in respiratory infection. HCoV-229E has been described as a rare cause of lower respiratory infection in immunocompetent adults. CASE PRESENTATION: We reported a 72-year-old man infected by HCoV-229E with rapid progression to acute respiratory distress syndrome, in conjunction with new onset atrial fibrillation, intensive care unit acquired weakness, and recurrent hospital acquired pneumonia. Clinical and radiological data were continuously collected. The absolute number of peripheral T cells and the level of complement components diminished initially and recovered after 2 months. The patient was successfully treated under intensive support care and discharged from the hospital after 3 months and followed. CONCLUSION:HCoV-229E might an essential causative agent of pulmonary inflammation and extensive lung damage. Supportive treatment was essential to HCoVs infection on account of a long duration of immunological recovery in critical HCoV-229E infection.
Entities:
Keywords:
Adult respiratory distress syndrome; Human coronavirus 229E; Immunology; Pneumonia
Authors: Victor Max Corman; Heather J Baldwin; Adriana Fumie Tateno; Rodrigo Melim Zerbinati; Augustina Annan; Michael Owusu; Evans Ewald Nkrumah; Gael Darren Maganga; Samuel Oppong; Yaw Adu-Sarkodie; Peter Vallo; Luiz Vicente Ribeiro Ferreira da Silva Filho; Eric M Leroy; Volker Thiel; Lia van der Hoek; Leo L M Poon; Marco Tschapka; Christian Drosten; Jan Felix Drexler Journal: J Virol Date: 2015-09-16 Impact factor: 5.103
Authors: A Bodson; P Becquevort; J Dwelshauvers; H Demol; L Michel; G P Alexandre; L Vanderbeck Journal: Ann Endocrinol (Paris) Date: 1982 Jul-Sep Impact factor: 2.478
Authors: Gregory E Antonio; K T Wong; David S C Hui; Alan Wu; Nelson Lee; Edmund H Y Yuen; C B Leung; T H Rainer; Peter Cameron; Sydney S C Chung; Joseph J Y Sung; Anil T Ahuja Journal: Radiology Date: 2003-06-12 Impact factor: 11.105